 |
Click Therapeutics
Last updated: July 21, 2024
David Benshoof Klein, Co-founder and CEO
USA | Funding: $946.4M (+)
Website: http://clicktherapeutics.com/
Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking cessation, that works as a phone app designed to help people stop smoking using input from Magellan Health, a behavioral healthcare company.
Website: http://clicktherapeutics.com/
Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking cessation, that works as a phone app designed to help people stop smoking using input from Magellan Health, a behavioral healthcare company.
